Stepping Through the Regulatory Maze: Are You in Compliance?

  • 5.1.2002 | 7:30 PM -

Hale and Dorr and Product Genesis present a panel discussion on managing the regulatory approval process in order to best position your company for compliance. Hale and Dorr partner Mark Heller will be a featured speaker along with Charles Brunner of Product Genesis, Inc. and Pamela Weagraff of MediSpectra, Inc.



Not sure where to start?

Let our Knowledge Navigator direct you to content specific to where you are on your journey.

Get Started!
Rss Feed
4.17.2026
Train-to-Test scaling explained: How to optimize your end-to-end AI compute budget for inference 
4.17.2026
Most enterprises can't stop stage-three AI agent threats, VentureBeat survey finds 
4.17.2026
Anthropic just launched Claude Design, an AI tool that turns prompts into prototypes and challenges Figma 
Featured
blog-launch-550x370

This blog post explains why a Section 409A valuation is essential for private companies issuing equity compensation.

4.13.2026
Don’t Let Australia’s R&D Tax Incentive Trigger Unintended US International Tax Cost Sharing Issues
10.13.2025
Back to Basics: Why Get a Section 409A Valuation?
10.6.2025
Back to Basics: How to Grant a Stock Option